Pfizer, AstraZeneca CEOs set to appear before U.K. lawmakers

In an effort to smooth approval for its $106 billion merger, Pfizer and AstraZeneca are set to meet UK regulators on Tuesday who are wary a deal will lead to British job cuts. For its part, Pfizer says it has already made legally binding commitments.